← All companies
Bio-Rad Laboratories, Inc.
BIO
Market cap$8.09 B
Rank#1065
SEC filings1,494
The table below shows Bio-Rad Laboratories, Inc.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $529.80M | $488.10M | $403.81M | $434.21M | $470.78M | $662.21M |
| Short-term investments | $1.01B | $1.18B | $1.20B | $1.36B | $399.13M | $328.91M |
| Receivables | $460.60M | $452.50M | $489.02M | $494.64M | $423.54M | $419.42M |
| Inventory | $740.70M | $760.00M | $780.52M | $719.32M | $572.24M | $622.25M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.